
|Articles|March 1, 1999
The American Journal of Managed Care
- March 1999
- Volume 5
- Issue 3
Dissecting Cost-Effectiveness Analysis for Preventive Interventions: A Guide for Decision Makers
Advertisement
Articles in this issue
over 26 years ago
Economic Impact of Delaying or Preventing AIDS in Persons with HIVover 26 years ago
Erectile Dysfunction: The Primary Care Practitioner's Viewover 26 years ago
Drug-Nutrient InteractionsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Flow Cytometry Tool Could Improve Treatment Monitoring in MS
5